oleanolic acid has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahbah, EI; Nabet, MS; Negida, A | 1 |
| Pawełczyk, A; Zaprutko, L | 1 |
2 other study(ies) available for oleanolic acid and Pneumonia, Viral
| Article | Year |
|---|---|
Purposing Saikosaponins for the treatment of COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Lymphocyte Activation; Molecular Docking Simulation; Oleanolic Acid; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Saponins; SARS-CoV-2 | 2020 |
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.
Topics: Antiviral Agents; Betacoronavirus; Cardiovascular Agents; Coronavirus Infections; COVID-19; Drug Repositioning; Drugs, Chinese Herbal; Humans; Oleanolic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |